Structure

Physi-Chem Properties

Molecular Weight:  540.04
Volume:  487.892
LogP:  4.144
LogD:  2.09
LogS:  -3.221
# Rotatable Bonds:  6
TPSA:  204.19
# H-Bond Aceptor:  12
# H-Bond Donor:  6
# Rings:  5
# Heavy Atoms:  13

MedChem Properties

QED Drug-Likeness Score:  0.161
Synthetic Accessibility Score:  2.978
Fsp3:  0.0
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.097
MDCK Permeability:  8.021275789360516e-06
Pgp-inhibitor:  0.008
Pgp-substrate:  0.003
Human Intestinal Absorption (HIA):  0.62
20% Bioavailability (F20%):  1.0
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.002
Plasma Protein Binding (PPB):  99.40904998779297%
Volume Distribution (VD):  0.265
Pgp-substrate:  0.7296844720840454%

ADMET: Metabolism

CYP1A2-inhibitor:  0.626
CYP1A2-substrate:  0.079
CYP2C19-inhibitor:  0.06
CYP2C19-substrate:  0.032
CYP2C9-inhibitor:  0.586
CYP2C9-substrate:  0.12
CYP2D6-inhibitor:  0.052
CYP2D6-substrate:  0.116
CYP3A4-inhibitor:  0.073
CYP3A4-substrate:  0.017

ADMET: Excretion

Clearance (CL):  2.932
Half-life (T1/2):  0.59

ADMET: Toxicity

hERG Blockers:  0.043
Human Hepatotoxicity (H-HT):  0.888
Drug-inuced Liver Injury (DILI):  0.988
AMES Toxicity:  0.007
Rat Oral Acute Toxicity:  0.243
Maximum Recommended Daily Dose:  0.96
Skin Sensitization:  0.289
Carcinogencity:  0.796
Eye Corrosion:  0.003
Eye Irritation:  0.632
Respiratory Toxicity:  0.847

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC248315

Natural Product ID:  NPC248315
Common Name*:   6-(3,3'-Dihydroxy-4'-Sulfooxy-Biphenyl-4-Yloxy)-2,8-Dihydroxy-Dibenzofuran-3-Carboxylic Acid
IUPAC Name:   2,8-dihydroxy-6-[2-hydroxy-4-(3-hydroxy-4-sulfooxyphenyl)phenoxy]dibenzofuran-3-carboxylic acid
Synonyms:  
Standard InCHIKey:  FRUOIAVWHGWBQO-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C25H16O12S/c26-13-7-15-14-9-17(27)16(25(30)31)10-22(14)36-24(15)23(8-13)35-20-3-1-11(5-18(20)28)12-2-4-21(19(29)6-12)37-38(32,33)34/h1-10,26-29H,(H,30,31)(H,32,33,34)
SMILES:  c1cc(c(cc1c1ccc(c(c1)O)OS(=O)(=O)O)O)Oc1cc(cc2c3cc(c(cc3oc12)C(=O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL251431
PubChem CID:   24178901
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000301] Benzofurans
        • [CHEMONTID:0000015] Dibenzofurans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21285 Cladophora socialis Species Cladophoraceae Eukaryota n.a. n.a. n.a. PMID[17949055]
NPO21285 Cladophora socialis Species Cladophoraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens IC50 = 1700.0 nM PMID[559970]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC248315 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9765 High Similarity NPC47883
0.9483 High Similarity NPC226725
0.9425 High Similarity NPC154527
0.9419 High Similarity NPC98546
0.9419 High Similarity NPC297807
0.9244 High Similarity NPC476640
0.9244 High Similarity NPC82217
0.9244 High Similarity NPC216842
0.9235 High Similarity NPC470704
0.9191 High Similarity NPC287243
0.9186 High Similarity NPC230619
0.9186 High Similarity NPC54098
0.9138 High Similarity NPC49667
0.9138 High Similarity NPC8127
0.9133 High Similarity NPC149846
0.9128 High Similarity NPC476641
0.9096 High Similarity NPC71260
0.9023 High Similarity NPC65885
0.9 High Similarity NPC295436
0.8966 High Similarity NPC174700
0.892 High Similarity NPC471841
0.8914 High Similarity NPC473834
0.8895 High Similarity NPC29411
0.8895 High Similarity NPC36320
0.8895 High Similarity NPC45449
0.8876 High Similarity NPC475996
0.8851 High Similarity NPC280493
0.8851 High Similarity NPC202470
0.8837 High Similarity NPC1706
0.8837 High Similarity NPC59295
0.8837 High Similarity NPC39305
0.8837 High Similarity NPC263092
0.8837 High Similarity NPC1755
0.8814 High Similarity NPC24258
0.8807 High Similarity NPC117450
0.8779 High Similarity NPC312056
0.8779 High Similarity NPC272722
0.8779 High Similarity NPC238995
0.8779 High Similarity NPC84515
0.8765 High Similarity NPC185526
0.875 High Similarity NPC476370
0.875 High Similarity NPC247964
0.8743 High Similarity NPC476279
0.8722 High Similarity NPC471842
0.8721 High Similarity NPC231758
0.8721 High Similarity NPC188486
0.8706 High Similarity NPC472461
0.8706 High Similarity NPC137100
0.8701 High Similarity NPC476374
0.8701 High Similarity NPC261471
0.8693 High Similarity NPC218533
0.8693 High Similarity NPC78830
0.8693 High Similarity NPC72696
0.8686 High Similarity NPC86477
0.8686 High Similarity NPC50394
0.8659 High Similarity NPC475783
0.8644 High Similarity NPC158226
0.8636 High Similarity NPC247136
0.8629 High Similarity NPC272560
0.8621 High Similarity NPC133065
0.8621 High Similarity NPC89131
0.8613 High Similarity NPC34089
0.8613 High Similarity NPC196179
0.8605 High Similarity NPC190487
0.8605 High Similarity NPC195832
0.8605 High Similarity NPC196879
0.8605 High Similarity NPC154304
0.8605 High Similarity NPC16935
0.8603 High Similarity NPC164384
0.8596 High Similarity NPC310794
0.8596 High Similarity NPC37606
0.858 High Similarity NPC247973
0.8579 High Similarity NPC269625
0.8579 High Similarity NPC174486
0.8571 High Similarity NPC39306
0.8571 High Similarity NPC259757
0.8564 High Similarity NPC222674
0.8556 High Similarity NPC23553
0.8556 High Similarity NPC77179
0.8555 High Similarity NPC188967
0.8555 High Similarity NPC300680
0.8555 High Similarity NPC130955
0.8547 High Similarity NPC99591
0.8547 High Similarity NPC227906
0.8539 High Similarity NPC28589
0.8539 High Similarity NPC248593
0.8531 High Similarity NPC99613
0.8531 High Similarity NPC165979
0.8531 High Similarity NPC163130
0.8531 High Similarity NPC49487
0.8529 High Similarity NPC125300
0.8523 High Similarity NPC277480
0.8516 High Similarity NPC240508
0.8516 High Similarity NPC107987
0.8514 High Similarity NPC272064
0.8508 High Similarity NPC476273
0.85 High Similarity NPC296018
0.85 High Similarity NPC154741
0.8497 Intermediate Similarity NPC176300
0.8497 Intermediate Similarity NPC253634
0.8497 Intermediate Similarity NPC19687
0.8497 Intermediate Similarity NPC115798
0.8497 Intermediate Similarity NPC204854
0.8497 Intermediate Similarity NPC193842
0.8497 Intermediate Similarity NPC22472
0.8497 Intermediate Similarity NPC152166
0.8497 Intermediate Similarity NPC9609
0.8497 Intermediate Similarity NPC7846
0.8497 Intermediate Similarity NPC18772
0.8497 Intermediate Similarity NPC4481
0.8497 Intermediate Similarity NPC143828
0.8497 Intermediate Similarity NPC130894
0.8497 Intermediate Similarity NPC105242
0.8497 Intermediate Similarity NPC25495
0.8497 Intermediate Similarity NPC300943
0.8497 Intermediate Similarity NPC18607
0.8497 Intermediate Similarity NPC261004
0.8497 Intermediate Similarity NPC288669
0.8497 Intermediate Similarity NPC191459
0.8492 Intermediate Similarity NPC233956
0.8488 Intermediate Similarity NPC45131
0.8483 Intermediate Similarity NPC28042
0.8483 Intermediate Similarity NPC476365
0.8478 Intermediate Similarity NPC47905
0.8478 Intermediate Similarity NPC139683
0.8478 Intermediate Similarity NPC73929
0.8475 Intermediate Similarity NPC76482
0.8475 Intermediate Similarity NPC234331
0.847 Intermediate Similarity NPC476170
0.8466 Intermediate Similarity NPC169471
0.8466 Intermediate Similarity NPC37183
0.8466 Intermediate Similarity NPC280893
0.8466 Intermediate Similarity NPC291110
0.8462 Intermediate Similarity NPC97523
0.8453 Intermediate Similarity NPC221820
0.8453 Intermediate Similarity NPC476773
0.8453 Intermediate Similarity NPC246877
0.8444 Intermediate Similarity NPC289244
0.8444 Intermediate Similarity NPC245975
0.8441 Intermediate Similarity NPC60848
0.8439 Intermediate Similarity NPC176665
0.8439 Intermediate Similarity NPC112954
0.8439 Intermediate Similarity NPC189179
0.8439 Intermediate Similarity NPC93376
0.8439 Intermediate Similarity NPC224137
0.8439 Intermediate Similarity NPC163524
0.8439 Intermediate Similarity NPC78302
0.8439 Intermediate Similarity NPC110070
0.8439 Intermediate Similarity NPC227192
0.8439 Intermediate Similarity NPC203891
0.8439 Intermediate Similarity NPC472438
0.8439 Intermediate Similarity NPC101830
0.8439 Intermediate Similarity NPC7973
0.8439 Intermediate Similarity NPC75215
0.8439 Intermediate Similarity NPC29841
0.8439 Intermediate Similarity NPC287979
0.8439 Intermediate Similarity NPC305663
0.8439 Intermediate Similarity NPC174908
0.8439 Intermediate Similarity NPC235215
0.8436 Intermediate Similarity NPC271848
0.8436 Intermediate Similarity NPC81332
0.8436 Intermediate Similarity NPC262580
0.8436 Intermediate Similarity NPC289396
0.8436 Intermediate Similarity NPC212038
0.8436 Intermediate Similarity NPC47386
0.843 Intermediate Similarity NPC80489
0.843 Intermediate Similarity NPC292385
0.843 Intermediate Similarity NPC125709
0.8427 Intermediate Similarity NPC216403
0.8427 Intermediate Similarity NPC186100
0.8427 Intermediate Similarity NPC41494
0.8424 Intermediate Similarity NPC304322
0.8421 Intermediate Similarity NPC27208
0.8418 Intermediate Similarity NPC29160
0.8415 Intermediate Similarity NPC36138
0.8415 Intermediate Similarity NPC246153
0.8415 Intermediate Similarity NPC228209
0.8412 Intermediate Similarity NPC260582
0.8409 Intermediate Similarity NPC67959
0.84 Intermediate Similarity NPC112418
0.8398 Intermediate Similarity NPC156955
0.8398 Intermediate Similarity NPC107244
0.8398 Intermediate Similarity NPC268533
0.8398 Intermediate Similarity NPC216307
0.8391 Intermediate Similarity NPC287458
0.8391 Intermediate Similarity NPC472877
0.8391 Intermediate Similarity NPC36354
0.8389 Intermediate Similarity NPC30550
0.8382 Intermediate Similarity NPC474520
0.8382 Intermediate Similarity NPC266960
0.8382 Intermediate Similarity NPC292107
0.8382 Intermediate Similarity NPC200388
0.8382 Intermediate Similarity NPC247017
0.8382 Intermediate Similarity NPC55619
0.8382 Intermediate Similarity NPC245546
0.8382 Intermediate Similarity NPC178854
0.8382 Intermediate Similarity NPC49824
0.8382 Intermediate Similarity NPC98661
0.8382 Intermediate Similarity NPC268161
0.8382 Intermediate Similarity NPC265511

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC248315 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8382 Intermediate Similarity NPD3882 Suspended
0.8352 Intermediate Similarity NPD6232 Discontinued
0.8343 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8315 Intermediate Similarity NPD7473 Discontinued
0.8276 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8266 Intermediate Similarity NPD2801 Approved
0.8258 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8258 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8258 Intermediate Similarity NPD6166 Phase 2
0.8232 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8229 Intermediate Similarity NPD3749 Approved
0.8218 Intermediate Similarity NPD3817 Phase 2
0.8167 Intermediate Similarity NPD3818 Discontinued
0.8122 Intermediate Similarity NPD5844 Phase 1
0.8101 Intermediate Similarity NPD3926 Phase 2
0.807 Intermediate Similarity NPD1512 Approved
0.8057 Intermediate Similarity NPD1465 Phase 2
0.8011 Intermediate Similarity NPD5402 Approved
0.8 Intermediate Similarity NPD1934 Approved
0.7979 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7953 Intermediate Similarity NPD1511 Approved
0.7933 Intermediate Similarity NPD5494 Approved
0.7921 Intermediate Similarity NPD7075 Discontinued
0.7892 Intermediate Similarity NPD6559 Discontinued
0.7889 Intermediate Similarity NPD1247 Approved
0.7886 Intermediate Similarity NPD6599 Discontinued
0.7877 Intermediate Similarity NPD919 Approved
0.7853 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7838 Intermediate Similarity NPD6797 Phase 2
0.7801 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7796 Intermediate Similarity NPD7251 Discontinued
0.779 Intermediate Similarity NPD6959 Discontinued
0.7784 Intermediate Similarity NPD7074 Phase 3
0.776 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7754 Intermediate Similarity NPD7808 Phase 3
0.7753 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7746 Intermediate Similarity NPD6799 Approved
0.773 Intermediate Similarity NPD7054 Approved
0.7697 Intermediate Similarity NPD6801 Discontinued
0.7688 Intermediate Similarity NPD7472 Approved
0.7667 Intermediate Similarity NPD7768 Phase 2
0.764 Intermediate Similarity NPD7411 Suspended
0.7632 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7624 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7614 Intermediate Similarity NPD5403 Approved
0.7614 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7609 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD4380 Phase 2
0.7556 Intermediate Similarity NPD7819 Suspended
0.7528 Intermediate Similarity NPD3226 Approved
0.75 Intermediate Similarity NPD2344 Approved
0.75 Intermediate Similarity NPD8434 Phase 2
0.75 Intermediate Similarity NPD5401 Approved
0.7487 Intermediate Similarity NPD3751 Discontinued
0.7471 Intermediate Similarity NPD3750 Approved
0.7447 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7435 Intermediate Similarity NPD8313 Approved
0.7435 Intermediate Similarity NPD8312 Approved
0.7429 Intermediate Similarity NPD6190 Approved
0.7418 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD7435 Discontinued
0.7405 Intermediate Similarity NPD7199 Phase 2
0.7401 Intermediate Similarity NPD2534 Approved
0.7401 Intermediate Similarity NPD2533 Approved
0.7401 Intermediate Similarity NPD2532 Approved
0.7391 Intermediate Similarity NPD6234 Discontinued
0.7366 Intermediate Similarity NPD3787 Discontinued
0.7356 Intermediate Similarity NPD1549 Phase 2
0.7353 Intermediate Similarity NPD943 Approved
0.7345 Intermediate Similarity NPD7390 Discontinued
0.7333 Intermediate Similarity NPD4287 Approved
0.733 Intermediate Similarity NPD2309 Approved
0.7318 Intermediate Similarity NPD920 Approved
0.7314 Intermediate Similarity NPD1243 Approved
0.7303 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD1510 Phase 2
0.7267 Intermediate Similarity NPD1607 Approved
0.7264 Intermediate Similarity NPD6777 Approved
0.7264 Intermediate Similarity NPD6781 Approved
0.7264 Intermediate Similarity NPD6779 Approved
0.7264 Intermediate Similarity NPD6776 Approved
0.7264 Intermediate Similarity NPD6778 Approved
0.7264 Intermediate Similarity NPD6780 Approved
0.7264 Intermediate Similarity NPD6782 Approved
0.7247 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD5404 Approved
0.7241 Intermediate Similarity NPD2935 Discontinued
0.7241 Intermediate Similarity NPD5406 Approved
0.7241 Intermediate Similarity NPD5408 Approved
0.7241 Intermediate Similarity NPD5405 Approved
0.7241 Intermediate Similarity NPD1551 Phase 2
0.7233 Intermediate Similarity NPD8151 Discontinued
0.7213 Intermediate Similarity NPD37 Approved
0.7211 Intermediate Similarity NPD7228 Approved
0.7209 Intermediate Similarity NPD447 Suspended
0.7207 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD7874 Approved
0.7198 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7191 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD4966 Approved
0.7189 Intermediate Similarity NPD4967 Phase 2
0.7189 Intermediate Similarity NPD4965 Approved
0.7188 Intermediate Similarity NPD5953 Discontinued
0.7184 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7184 Intermediate Similarity NPD3748 Approved
0.7175 Intermediate Similarity NPD4628 Phase 3
0.7159 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD1240 Approved
0.7143 Intermediate Similarity NPD2796 Approved
0.7143 Intermediate Similarity NPD8150 Discontinued
0.7122 Intermediate Similarity NPD7871 Phase 2
0.7122 Intermediate Similarity NPD7870 Phase 2
0.7119 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7119 Intermediate Similarity NPD2800 Approved
0.7111 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD230 Phase 1
0.7102 Intermediate Similarity NPD2346 Discontinued
0.709 Intermediate Similarity NPD7229 Phase 3
0.7088 Intermediate Similarity NPD1653 Approved
0.7086 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7073 Intermediate Similarity NPD7697 Approved
0.7073 Intermediate Similarity NPD7698 Approved
0.7073 Intermediate Similarity NPD7696 Phase 3
0.7019 Intermediate Similarity NPD7701 Phase 2
0.7018 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7015 Intermediate Similarity NPD6535 Approved
0.7015 Intermediate Similarity NPD6534 Approved
0.7006 Intermediate Similarity NPD1471 Phase 3
0.7 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD7783 Phase 2
0.6989 Remote Similarity NPD2799 Discontinued
0.6983 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6974 Remote Similarity NPD7685 Pre-registration
0.6959 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6957 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6944 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6943 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6936 Remote Similarity NPD3764 Approved
0.6936 Remote Similarity NPD2313 Discontinued
0.6919 Remote Similarity NPD7801 Approved
0.6912 Remote Similarity NPD7700 Phase 2
0.6912 Remote Similarity NPD7699 Phase 2
0.6911 Remote Similarity NPD5710 Approved
0.6911 Remote Similarity NPD5711 Approved
0.691 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6907 Remote Similarity NPD7286 Phase 2
0.6898 Remote Similarity NPD8455 Phase 2
0.6897 Remote Similarity NPD6233 Phase 2
0.6889 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6875 Remote Similarity NPD8319 Approved
0.6875 Remote Similarity NPD8320 Phase 1
0.6866 Remote Similarity NPD7907 Approved
0.6865 Remote Similarity NPD7458 Discontinued
0.6862 Remote Similarity NPD2296 Approved
0.6859 Remote Similarity NPD8127 Discontinued
0.6857 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6857 Remote Similarity NPD1613 Approved
0.6856 Remote Similarity NPD7177 Discontinued
0.6854 Remote Similarity NPD6100 Approved
0.6854 Remote Similarity NPD6099 Approved
0.6845 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6842 Remote Similarity NPD1203 Approved
0.6842 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6842 Remote Similarity NPD7211 Clinical (unspecified phase)
0.6839 Remote Similarity NPD6798 Discontinued
0.6839 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6818 Remote Similarity NPD1933 Approved
0.6802 Remote Similarity NPD7240 Approved
0.6796 Remote Similarity NPD7003 Approved
0.6788 Remote Similarity NPD5242 Approved
0.6779 Remote Similarity NPD6823 Phase 2
0.6774 Remote Similarity NPD4665 Approved
0.6774 Remote Similarity NPD4111 Phase 1
0.6768 Remote Similarity NPD7549 Discontinued
0.6765 Remote Similarity NPD9269 Phase 2
0.6753 Remote Similarity NPD2403 Approved
0.6746 Remote Similarity NPD7680 Approved
0.6736 Remote Similarity NPD6808 Phase 2
0.6727 Remote Similarity NPD5619 Clinical (unspecified phase)
0.6723 Remote Similarity NPD6355 Discontinued
0.6704 Remote Similarity NPD4308 Phase 3
0.6686 Remote Similarity NPD3027 Phase 3
0.6686 Remote Similarity NPD7095 Approved
0.6684 Remote Similarity NPD4288 Approved
0.6684 Remote Similarity NPD2163 Approved
0.6683 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6667 Remote Similarity NPD7784 Clinical (unspecified phase)
0.6667 Remote Similarity NPD2354 Approved
0.6651 Remote Similarity NPD2494 Approved
0.6651 Remote Similarity NPD3452 Approved
0.6651 Remote Similarity NPD2493 Approved
0.6651 Remote Similarity NPD3450 Approved
0.6648 Remote Similarity NPD3268 Approved
0.6648 Remote Similarity NPD411 Approved
0.6647 Remote Similarity NPD1470 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data